Category Healthcare
SUB CATEGORIES General  |  HIV |  Medical Schemes | 

Medical scheme inflation explained

07 November 2019 Alexander Forbes
Tracy Janssens – Branch Head at Alexander Forbes Health

Tracy Janssens – Branch Head at Alexander Forbes Health

2020 medical scheme increases of between 8% and 12% are going to be a bitter pill for members to swallow in the current economic environment, and Tracy Janssens – Branch Head at Alexander Forbes Health believes it could result in option downgrades and cancelation of medical scheme memberships.

Why are increases in the medical scheme environment so high?
One needs to compare medical scheme contribution inflation and medical care and healthcare expense inflation trends to consumer price index (CPI) inflation. Over the past 18 years, CPI inflation has been 5.7% a year, medical care and health expenses inflation 7.5% a year, while medical scheme contribution inflation has tracked at 7.6% per year.
Over this period, medical scheme increases exceeded CPI inflation by at least 1.9% a year. The gap between medical scheme contribution inflation and CPI inflation has reduced in recent years, most likely as a result of efforts by medical schemes to manage costs charged by providers; buy-downs to lower cost benefits; changes to family size, possibly removing dependents due to affordability constraints; new entrants joining low-income options.
The general observation in the industry is that medical inflation will be about 2% to 3% higher than CPI over the long term. Increases in a particular year may be significantly higher due to adverse claims experience. The deviation from CPI is mainly due to:

• Tariffs: high increases in health care service provider fees and an increase in hospital admission rates
• Utilisation:
• The requirement to maintain medical aid scheme reserves of at least 25% of gross contribution income
• Certain benefit enhancements.

Medical schemes’ audited financial results which include size scale, membership growth, membership profile, financial results and solvency levels provide a good indication of the scheme’s performance and an indicator of the increase for the following year. Schemes need to balance all these factors to grow consistently while achieving a positive operating result. Medical scheme that are running at a financial loss and have not met the required solvency, may need to take corrective measures. This can be done by introducing higher increases or reducing benefits. Schemes that are performing well in most key indictors may give back to the members by way of lower increases. Traditionally, high cover and network options are under the most pressure and schemes are likely to make some corrections on these plans in 2020.
Schemes will use the following factors to determine their 2020 increases:

1. in 2019 and 2020, respectively.
2. Cost increase assumptions analysis for 2019 showed that scheme demographic and utilisation factors are projected to add about 1% to 3.9% to the total cost increases for medical schemes.
3. Scheme performance as detailed above.

Choosing the right medical scheme option is a complex decision, with 20 open medical schemes currently available in South Africa, each offering several benefit options. It is therefore crucial that a medical scheme broker assists members with their individual needs based on healthcare requirements and affordability.

Quick Polls


There are countless articles written about South Africa’s poor retirement outcomes. Which of the following would you single out as the biggest contributor to local savers not accumulating enough to buy an adequate and sustainable pension?


Lack of personal accountability
Poor participation in formal retirement funds
Reluctance to seek financial advice early on
SA’s high unemployment rate
fanews magazine
FAnews April 2022 Get the latest issue of FAnews

This month's headlines

The ethical core of insurance relationships
Debarment… a double whammy
A beginner’s guide to scaling the Tech Mountain
Leadership, climate and cybercrime… SA’s top risks
Unpacking the retirement reform developments
Subscribe now